| Discovery is in our DNA
U.Va. Innovation launched the University of Virginia’s first crowdfunding website this week, enabling alumni and others to make targeted, tax-deductible donations in support of specific research and development projects under way at the University. The site, accessible at read more ».
The Board of Directors of the Virginia Biosciences Health Research Corporation (VBHRC) today announced that it has selected Michael Grisham as VBHRC President and CEO. Grisham has served as Founder, Managing Member and CEO of GPB Scientific LLC since 2002. Boasting 21 years of experience in the ... read more ».
Lyme disease is at epidemic levels in Northern Virginia, so elected officials gathered at George Mason University’s Prince William Campus last week to discuss the latest developments for detecting and treating the disease. Legislators and staff from both the Virginia House of Delegates and the ... read more ».
Recipharm Pharmaceutical Development AB and Synthonics, Inc. have announced formation of a Joint Promotion Agreement. The contract, the first of its kind to be entered into between the two companies, will provide Recipharm customers full access to Synthonics’ metal coordination chemistry, ... read more ».
Virginia Tech President Charles W. Steger will step down as university president. The university’s board of visitors will assemble a search committee immediately. Steger will remain as president until the search concludes and his replacement begins work. “When one is totally absorbed in ... read more ».
The University of Virginia Cancer Center has opened a Request for Proposals (RFP) for the UVA Cancer Center Technology Partnership Initiative (CCTPI). The initiative is designed to support public-private research partnerships between the UVA Cancer Center and Virginia technology and biotechnology ... read more ».
Commonwealth Biotechnologies, Inc. (“CBI”) has announced that its Plan of Reorganization from Chapter 11 bankruptcy proceedings has become effective today. Pursuant to such plan, CBI is currently in the process of finalizing definitive documentation with HedgePath, LLC (“HedgePath”), a drug ... read more ».
Individuals, Organizations, Milestones Honored at Event Commemorating 20th Anniversary of Virginia Bio On Thursday, May 2, Virginia Bio, the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia, will recognize 20 exemplary ... read more ».
algorithmRx, LLC, headquartered in Richmond, Virginia, has received a rare perfect score on its federalSmall Business Innovation Research (SBIR) grant for its innovative new Statin Manager™ technology. SBIR grants are peer-reviewed by each Federal agency that participates in the SBIR program and ... read more ».
The Center for Innovative Technology (CIT) finalized a second $100,000 investment in Charlottesville, VA- based Lewis and Clark Pharmaceuticals, Inc.. This second tranche follows an initial $100,000 CIT GAP fund investment in Lewis and Clark in November of 2012 and was contingent upon the ... read more ».